Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

148.24 +3.65 (+2.52%)
Streaming Delayed Price Updated: 9:31 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 660,809
Open 148.74
Bid (Size) 148.21 (2)
Ask (Size) 148.22 (2)
Prev. Close 144.59
Today's Range 148.02 - 148.99
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.21%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
From Johnson & Johnson
Via Business Wire
3 No-Brainer Stocks to Buy With $200 Right Now
You don't need a mountain of cash to grow your wealth on Wall Street. 
Via The Motley Fool

Performance

YTD
-7.33%
-7.33%
1 Month
-6.05%
-6.05%
3 Month
-6.63%
-6.63%
6 Month
-0.07%
-0.07%
1 Year
-9.39%
-9.39%

More News

Read More
Spotlight on Johnson & Johnson: Analyzing the Surge in Options Activity
Via Benzinga
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Healthcare Stocks
Via InvestorPlace
3 Stocks Mega Investors Are Buying
Via MarketBeat
Topics Regulatory Compliance
Exposures Legal Regulatory
Johnson & Johnson Stock: Buy, Sell, or Hold?
Via The Motley Fool
US Stock: Johnson & Johnson
Via Talk Markets
Slump Survivors: 3 Stocks That Will Outlast the S&P 500 Downturn
Via InvestorPlace
Topics Stocks
Exposures US Equities
Cutting Edge Picks: 3 Med Tech Stocks With Room to Run
Via InvestorPlace
Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
Via Benzinga
Johnson & Johnson Is a King of Dividend Safety
Via The Motley Fool
7 Retirement Stocks to Buy at a 52-Week Low in April
Via InvestorPlace
Topics Retirement
Exposures Pension
Balancing Dividends and Fundamentals: The Case of NYSE:JNJ.
Via Chartmill
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
Via Talk Markets
2 Top Growth Stocks to Buy Right Now and Hold Forever
Via The Motley Fool
Better Dividend Stock: AbbVie or Johnson & Johnson?
Via The Motley Fool
5 Stocks In Focus On Their Recent Dividend Hikes
Via Talk Markets
7 Stocks to Buy if Inflation Continues to Reign in 2024
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Generational Wealth Builders: 3 Stocks to Own for Decades of Gains
Via InvestorPlace
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Via Investor's Business Daily
Steady Eddies: 7 Rock-Solid Stocks to Anchor Your Portfolio in April
Via InvestorPlace
How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?
Via InvestorPlace
The Top 3 Small-Cap Stocks to Buy in April 2024
Via InvestorPlace
3 Long-Term Stocks to Buy on the Dip: April 2024
Via InvestorPlace
7 blue chip stocks to Buy on the Dip: April 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.